Cited by 247Cancer, Hypoxia, and MetabolismPI3K/AKT/mTOR signaling in cancerMetabolism, Diabetes, and Cancer

MYC and tumor metabolism: chicken and egg

Open access
Dejure, Francesca R, Eilers, Martin·2017·The EMBO Journal

Abstract

Transcription factors of the MYC family are deregulated in the majority of all human cancers. Oncogenic levels of MYC reprogram cellular metabolism, a hallmark of cancer development, to sustain the high rate of proliferation of cancer cells. Conversely, cells need to modulate MYC function according to the availability of nutrients, in order to avoid a metabolic collapse. Here, we review recent evidence that the multiple interactions of MYC with cell metabolism are mutual and review mechanisms that control MYC levels and function in response to metabolic stress situations. The main hypothesis we put forward is that regulation of MYC levels is an integral part of the adaptation of cells to nutrient deprivation. Since such mechanisms would be particularly relevant in tumor cells, we propose that-in contrast to growth factor-dependent controls-they are not disrupted during tumorigenesis and that maintaining flexibility of expression is integral to MYC's oncogenic function.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.15252/embj.201796438

Cites

127 of 127 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Many tumors driven by oncogenic KRAS and MYC reprogram metabolism to consume and rely more on glutamine for catabolic and anabolic pathways.

    “Many tumors driven by oncogenic KRAS and its downstream effector, the transcription factor MYC, exhibit metabolic reprogramming to consume and rely more on glutamine for both catabolic to anabolic pathways55,56.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

2 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Dejure, F. R., & Eilers, M.
Affiliations
University of Würzburg (DE)
Corresponding author
Eilers, Martin
Venue
The EMBO Journal
Published
2017-12-01
Volume
36
Issue
23
Pages
3409-3420
ISSN
  • 0261-4189 (ISSN-L)
  • 1460-2075
OpenAlex
W2767348608
Cited by
240
References
127
Citations by year
2026: 13 · 2025: 24 · 2024: 21 · 2023: 30 · 2022: 29 · 2021: 43 · 2020: 31 · 2019: 35 · 2018: 13
FWCI
2.20
Type
journal article
Language
en
Open access
Locations
  • The EMBO Journal (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
Deutsche Forschungsgemeinschaft (DFG222/12‐1)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords
c-Myc, cancer metabolism, metabolic reprogramming, nutrient deprivation, metabolic stress, MYC regulation, carcinogenesis
MeSH terms
Forkhead Box Protein O1, Mechanistic Target of Rapamycin Complex 1, Animals, Glucose, Glutamine, Humans, Neoplasms, Nucleotides, Stress, Physiological, Biogenic Polyamines, Genes, myc, Proto-Oncogene Proteins c-myc, Apoptosis, Metabolic Networks and Pathways

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review